OMIC
Closed
Singular Genomics Systems Inc
20.01
0.00 (0.00%)
Last Update: 21 Feb 2025 17:30:00
Yesterday: 20.01
Day's Range: 20.01 - 20.01
Send
sign up or login to leave a comment!
When Written:
1.18
Singular Genomics Systems Inc. is a biotechnology company that develops and manufactures advanced genomic analysis technologies. The company was founded in 2016 and is headquartered in San Diego, California.
Singular Genomics Systems specializes in single-cell analysis, which allows researchers to study individual cells and their unique genetic makeup. The company's flagship product is the Singular Cell Prep System, which automates the process of isolating and preparing single cells for analysis.
The company's technology has applications in a wide range of fields, including cancer research, drug discovery, and developmental biology. Singular Genomics Systems has partnerships with leading research institutions and biotech companies, and has received funding from investors such as Illumina and Foresite Capital.
In 2021, Singular Genomics Systems went public through a merger with a special purpose acquisition company (SPAC) called Novo Holdings Acquisition Corp II. The combined company is listed on the NASDAQ stock exchange under the ticker symbol OMIC.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Singular Genomics Systems specializes in single-cell analysis, which allows researchers to study individual cells and their unique genetic makeup. The company's flagship product is the Singular Cell Prep System, which automates the process of isolating and preparing single cells for analysis.
The company's technology has applications in a wide range of fields, including cancer research, drug discovery, and developmental biology. Singular Genomics Systems has partnerships with leading research institutions and biotech companies, and has received funding from investors such as Illumina and Foresite Capital.
In 2021, Singular Genomics Systems went public through a merger with a special purpose acquisition company (SPAC) called Novo Holdings Acquisition Corp II. The combined company is listed on the NASDAQ stock exchange under the ticker symbol OMIC.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!